QUICK CONTACT FORM

How injury occurred & injuries

Submitting does not create an
Attorney/Client relationship

    Largest Dangerous      Drug Settlements

Redux

A middle-aged woman sustained serious heart valve injury (i.e. primary pulmonary hypertension) from taking a prescribed diet drug Redux, which contains Fen/Phen. Our firm maintained joint responsibility with an experienced drug injury firm who settled the case.
$2.5 Million Settlement

Ephedra

A wife and mother of two children died of a cerebral hemorrhage after taking an over the counter diet drug diet drug containing Ephedra. The deceased’s husband contacted our firm for help. Our firm maintained joint responsibility with an experienced product liability attorney who settled the case.
$900,000 Settlement

PPA

We were co-counsel in a case involving a dietary supplement with PPA. The client suffered a stroke and had a brain bleed that required two surgeries. Our firm maintained joint responsibility with an experienced product liability attorney who settled the case.
$ 750,000 Settlement

Paxil

A teenager committed suicide after taking an anti-depressant drug for several weeks. The young boy’s life was cut short just one week before his birthday. Our firm maintained joint responsibility with an experienced product liability attorney who settled the case.
$1.25 Million Settlement

Our client was the mother of a one year old child who was born with a complex cardiovascular condition. The child was diagnosed with arterial septal defect, ventricular septal defect and congestive heart failure, all conditions caused by the mother's use of Paxil during the first trimester of her pregnancy. Our firm maintained joint responsibility with an experienced drug injury firm who settled the case.
$800,000 Settlement

Baycol

When Baycol was removed from the market in 2001, we were contacted by many Rhode Islanders who were injured by this medication.  Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, who was successful in negotiating a multi-million dollar settlement for several clients.
$2 Million in total Settlements

Zyprexa

Due to taking the drug zyprexa, a number of our clients developed type 2 diabetes as a side effect. Our firm maintained joint responsibility with a pharmaceutical litigation law firm, who was successful in negotiating a multi-million dollar settlement for our clients.
$3.8 Million in total Settlements

A Connecticut man was diagnosed with Type II diabetes after using the medication, Zyprexa.  Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, and the case was settled out of court.
$500,000 Settlement

Botox Side Effects - Personal Injury Attorney Law Firm

FDA Notifies Public of Adverse Reactions Linked to Botox Use

The U.S. Food and Drug Administration (FDA) recently announced that it would undertake a safety review of Botox, Botox Cosemtic and Myobloc. The announcement came after the FDA received reports of serious adverse reaction, including respiratory failure and even death.

  • Botox (botulinum type A) is approved by the FDA for treatment of conditions such as blepharospasm (spasms of the eyelids) and cervical dystonia (severe neck muscle spasms).
  • Botox Cosmetic also, botulinum type A is approved for temporary improvement in the appearance of moderate to severe facial frown lines.
  • Myobloc or botulinum type B is approved for treatment of adults with cervical dystonia.

According to FDA the adverse reactions involved Botox injections for FDA approved and non-approved or “off label” usages. Off-label uses, though not prohibited or necessarily inappropriate, are not FDA approved. Some of the most serious injuries occurred in children treated for limb spasticity associated with cerebral palsy. Treatment of spasticity is not an FDA approved use of Botulism toxins in adults or children.

The adverse events appear to be related to the spread of the toxin to areas in the body beyond the injection site and mimic symptoms of botulism, which may include difficulty swallowing, weakness and breathing problems.

The agency is not advising health care professionals to discontinue prescribing these products at this time. It will continue its review of safety data from clinical studies submitted by the drug’s manufacturer, post marketing adverse events reports and medical literature before issuing any public notice regarding it’s conclusions, recommendations and any regulatory actions.

Contact the Law Offices of d'Oliveira & Associates

If you or a loved one suffered a serious injury or death as a possible result of using Botox or Myobloc, you may want to contact a Botox attorney or a Myobloc attorney. An injury lawyer familiar with new developments in the investigation of these products may be able to help you make important personal and legal decisions.

Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878 or fill out a contact form for a free legal consultation.